Consumer goods analyst Austin Smith discusses Walgreen's future prospects. The pharmacy recently made up with Express Scripts after their fallout, although CVS Caremark will continue to profit from the new customers that switched due to the Express Scripts controversy. While many investors are newly optimistic about Walgreen, Austin thinks the company will struggle to woo back lost customers, and is still bearish looking forward.
If you are looking for something different, then you should check out our new free report, The Motley Fool's Top Stock for 2012. In it, our chief investment officer identifies his favorite company for the year. To access the report before the rest of the market catches on, click here -- it's absolutely free.
The article Is Walgreen Still Bleeding? originally appeared on Fool.com.Austin Smith has no positions in the stocks mentioned above. Isaac Pino has no positions in the stocks mentioned above. The Motley Fool owns shares of Express Scripts. Motley Fool newsletter services recommend Express Scripts. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.